Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaPaul M. Barr, Margaret M. Briehl, Thomas P. Miller et al.|Blood|2014Cited by 37
Chronic Lymphocytic Leukemia in Young AdultsCatherine Spier, Brian P. Tudor, Carl R. Kjeldsberg et al.|American Journal of Clinical Pathology|1985Cited by 5